State Street Corp Cassava Sciences Inc Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Cassava Sciences Inc stock. As of the latest transaction made, State Street Corp holds 873,946 shares of SAVA stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

873,946

Previous 996,662 12.31%

Holding current value

$1.89 Million

Previous $2.35 Million 44.3%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.5 - $3.02 $184,074 - $370,602	-122,716 Reduced 12.31%	873,946 $1.31 Million
Q4 2024 Feb 14, 2025	SELL	$2.29 - $32.18 $380,339 - $5.34 Million	-166,087 Reduced 14.28%	996,662 $2.35 Million
Q3 2024 Nov 14, 2024	SELL	$9.57 - $35.08 $136,161 - $499,118	-14,228 Reduced 1.21%	1,162,749 $34.2 Million
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $1.03 Million - $2.18 Million	83,499 Added 7.64%	1,176,977 $14.5 Million
Q1 2024 May 15, 2024	BUY	$18.44 - $26.41 $439,406 - $629,323	23,829 Added 2.23%	1,093,478 $22.2 Million
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $556,905 - $1.33 Million	44,059 Added 4.3%	1,069,649 $24.1 Million
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $1.22 Million - $1.86 Million	73,505 Added 7.72%	1,025,590 $17.1 Million
Q2 2023 Aug 14, 2023	SELL	$21.59 - $27.88 $2.31 Million - $2.98 Million	-106,864 Reduced 10.09%	952,085 $23.3 Million
Q1 2023 May 15, 2023	BUY	$23.46 - $36.44 $1.52 Million - $2.37 Million	64,903 Added 6.53%	1,058,949 $25.5 Million
Q4 2022 Feb 14, 2023	SELL	$27.82 - $44.16 $89,107 - $141,444	-3,203 Reduced 0.32%	994,046 $29.4 Million
Q3 2022 Nov 15, 2022	SELL	$16.33 - $51.06 $46,034 - $143,938	-2,819 Reduced 0.28%	997,249 $41.7 Million
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $927,951 - $2.07 Million	-53,888 Reduced 5.11%	1,000,068 $28.1 Million
Q1 2022 May 16, 2022	BUY	$32.6 - $53.05 $2.54 Million - $4.13 Million	77,830 Added 7.97%	1,053,956 $39.1 Million
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $1.36 Million - $3.37 Million	37,040 Added 3.94%	976,126 $42.7 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $2.89 Million - $9.36 Million	69,208 Added 7.96%	939,086 $58.3 Million
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $5.9 Million - $16.5 Million	183,568 Added 26.75%	869,878 $74.3 Million
Q1 2021 May 17, 2021	BUY	$7.09 - $87.95 $1.69 Million - $20.9 Million	237,758 Added 53.01%	686,310 $30.9 Million
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $652,179 - $1.18 Million	96,050 Added 27.25%	448,552 $3.06 Million
Q3 2020 Nov 10, 2020	BUY	$2.86 - $11.51 $336,896 - $1.36 Million	117,796 Added 50.19%	352,502 $4.06 Million
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $478,800 - $2.26 Million	234,706 New	234,706 $723,000

Others Institutions Holding SAVA

# of Institutions

153

Shares Held

15.7M

Call Options Held

1.67M

Put Options Held

1.26M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $86.6M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cassava Sciences Inc Transaction History